Terms: = Germ cell tumor AND EML4, ENSG00000143924, 27436
32 results:
1. Genomic and epigenomic re-categorization of congenital glioblastoma and desmoplastic infantile ganglioglioma.
Gilani A; Siddiq Z; Kissell E; Kasson J; Kleinschmidt-DeMasters BK
Childs Nerv Syst; 2023 Jul; 39(7):1861-1868. PubMed ID: 36707425
[TBL] [Abstract] [Full Text] [Related]
2. Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
[TBL] [Abstract] [Full Text] [Related]
3. Identification of fusions with potential clinical significance in melanoma.
Moran JMT; Le LP; Nardi V; Golas J; Farahani AA; Signorelli S; Onozato ML; Foreman RK; Duncan LM; Lawrence DP; Lennerz JK; Dias-Santagata D; Hoang MP
Mod Pathol; 2022 Dec; 35(12):1837-1847. PubMed ID: 35871080
[TBL] [Abstract] [Full Text] [Related]
4. Observed progression from melanosis with melanocyte hyperplasia to sinonasal melanoma with distant metastasis and a unique genetic rearrangement.
Salari B; Duncan LM; Lennerz JK; Holbrook EH; Emerick KS; Foreman RK
J Cutan Pathol; 2021 Jul; 48(7):948-953. PubMed ID: 33694261
[TBL] [Abstract] [Full Text] [Related]
5. [Ceritinib in the treatment of an adult patient with advanced neuroblastoma positive to the somatic activating mutation of ALK F1174L.].
Soto Parra HJ; Noto L; Aiello MM
Recenti Prog Med; 2020 Dec; 111(12):58e-62e. PubMed ID: 33362184
[TBL] [Abstract] [Full Text] [Related]
6. NTRK and ALK rearrangements in malignant pleural mesothelioma, pulmonary neuroendocrine tumours and non-small cell lung cancer.
Leal JL; Peters G; Szaumkessel M; Leong T; Asadi K; Rivalland G; Do H; Senko C; Mitchell PL; Quing CZ; Dobrovic A; Thapa B; John T
Lung Cancer; 2020 Aug; 146():154-159. PubMed ID: 32540558
[TBL] [Abstract] [Full Text] [Related]
7. Targeted next generation sequencing (NGS) to classify melanocytic neoplasms.
Zarabi SK; Azzato EM; Tu ZJ; Ni Y; Billings SD; Arbesman J; Funchain P; Gastman B; Farkas DH; Ko JS
J Cutan Pathol; 2020 Aug; 47(8):691-704. PubMed ID: 32291779
[TBL] [Abstract] [Full Text] [Related]
8. Targetable molecular alterations in congenital glioblastoma.
Gilani A; Donson A; Davies KD; Whiteway SL; Lake J; DeSisto J; Hoffman L; Foreman NK; Kleinschmidt-DeMasters BK; Green AL
J Neurooncol; 2020 Jan; 146(2):247-252. PubMed ID: 31875306
[TBL] [Abstract] [Full Text] [Related]
9. A case of primary pulmonary atypical carcinoid with eml4-ALK rearrangement.
Liu N; Wang J; Fu X; Zheng X; Gao H; Tian T; Ruan Z; Yao Y
Cancer Biol Ther; 2020; 21(1):12-16. PubMed ID: 31559892
[TBL] [Abstract] [Full Text] [Related]
10. [Diagnosis of lung biopsy employing the 2015 WHO criteria and detection of related oncogenic driver mutations].
Fang F; Qiao XB; Yang L; Di J; Hu ST; Liu DG; Lyu N
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):270-275. PubMed ID: 30955261
[No Abstract] [Full Text] [Related]
11. A combined gene expression tool for parallel histological prediction and gene fusion detection in non-small cell lung cancer.
Karlsson A; Cirenajwis H; Ericson-Lindquist K; Brunnström H; Reuterswärd C; Jönsson M; Ortiz-Villalón C; Hussein A; Bergman B; Vikström A; Monsef N; Branden E; Koyi H; de Petris L; Micke P; Patthey A; Behndig AF; Johansson M; Planck M; Staaf J
Sci Rep; 2019 Mar; 9(1):5207. PubMed ID: 30914778
[TBL] [Abstract] [Full Text] [Related]
12. Desmoplastic Infantile Ganglioglioma/Astrocytoma (DIG/DIA) Are Distinct Entities with Frequent BRAFV600 Mutations.
Wang AC; Jones DTW; Abecassis IJ; Cole BL; Leary SES; Lockwood CM; Chavez L; Capper D; Korshunov A; Fallah A; Wang S; Ene C; Olson JM; Geyer JR; Holland EC; Lee A; Ellenbogen RG; Ojemann JG
Mol Cancer Res; 2018 Oct; 16(10):1491-1498. PubMed ID: 30006355
[TBL] [Abstract] [Full Text] [Related]
13. Overcoming Resistance to Targeted Anticancer Therapies through Small-Molecule-Mediated MEK Degradation.
Peh J; Boudreau MW; Smith HM; Hergenrother PJ
Cell Chem Biol; 2018 Aug; 25(8):996-1005.e4. PubMed ID: 29909991
[TBL] [Abstract] [Full Text] [Related]
14. MEK inhibitor trametinib does not prevent the growth of anaplastic lymphoma kinase (ALK)-addicted neuroblastomas.
Umapathy G; Guan J; Gustafsson DE; Javanmardi N; Cervantes-Madrid D; Djos A; Martinsson T; Palmer RH; Hallberg B
Sci Signal; 2017 Nov; 10(507):. PubMed ID: 29184034
[TBL] [Abstract] [Full Text] [Related]
15. ALK Inhibitor Response in Melanomas Expressing
Couts KL; Bemis J; Turner JA; Bagby SM; Murphy D; Christiansen J; Hintzsche JD; Le A; Pitts TM; Wells K; Applegate A; Amato C; Multani P; Chow-Maneval E; Tentler JJ; Shellman YG; Rioth MJ; Tan AC; Gonzalez R; Medina T; Doebele RC; Robinson WA
Mol Cancer Ther; 2018 Jan; 17(1):222-231. PubMed ID: 29054983
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, tumor Mutational Burden, and Hypermutation Signatures.
Johnson A; Severson E; Gay L; Vergilio JA; Elvin J; Suh J; Daniel S; Covert M; Frampton GM; Hsu S; Lesser GJ; Stogner-Underwood K; Mott RT; Rush SZ; Stanke JJ; Dahiya S; Sun J; Reddy P; Chalmers ZR; Erlich R; Chudnovsky Y; Fabrizio D; Schrock AB; Ali S; Miller V; Stephens PJ; Ross J; Crawford JR; Ramkissoon SH
Oncologist; 2017 Dec; 22(12):1478-1490. PubMed ID: 28912153
[TBL] [Abstract] [Full Text] [Related]
17. The role of the ALK receptor in cancer biology.
Hallberg B; Palmer RH
Ann Oncol; 2016 Sep; 27 Suppl 3():iii4-iii15. PubMed ID: 27573755
[TBL] [Abstract] [Full Text] [Related]
18. Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
Cha S; Lee J; Shin JY; Kim JY; Sim SH; Keam B; Kim TM; Kim DW; Heo DS; Lee SH; Kim JI
BMC Cancer; 2016 Feb; 16():170. PubMed ID: 26925973
[TBL] [Abstract] [Full Text] [Related]
19. The landscape of fusion transcripts in spitzoid melanoma and biologically indeterminate spitzoid tumors by RNA sequencing.
Wu G; Barnhill RL; Lee S; Li Y; Shao Y; Easton J; Dalton J; Zhang J; Pappo A; Bahrami A
Mod Pathol; 2016 Apr; 29(4):359-69. PubMed ID: 26892443
[TBL] [Abstract] [Full Text] [Related]
20. Survival but not brain metastasis response relates to lung cancer mutation status after radiosurgery.
Shin SM; Cooper BT; Chachoua A; Butler J; Donahue B; Silverman JS; Kondziolka D
J Neurooncol; 2016 Feb; 126(3):483-91. PubMed ID: 26520640
[TBL] [Abstract] [Full Text] [Related]
[Next]